TruAlt Bioenergy Q2 FY27 IPO Proceeds Utilization Report Shows Minimal Deviations
Trualt Bioenergy Ltd 路 Others (Uncategorized) 路 31 Oct 2026, 12:56 am
TruAlt Bioenergy Q2 FY27 IPO Proceeds Utilization Report Shows Minimal Deviations Crisil Ratings reported that TruAlt Bioenergy utilized Rs 741.22 crore of its Rs 750.00 crore gross IPO proceeds as of 30th Sep'26, leaving Rs 8.78 crore unutilized. Net issue proceeds of Rs 657.04 crore saw Rs 656.73 crore deployed, including Rs 425.00 crore for working capital and Rs 81.36 crore for general corporate purposes, both fully utilized by 31st Mar'26. Multi-feedstock capex reached Rs 150.37 crore against Rs 150.68 crore budgeted, with remaining unutilized funds held across monitoring and public offer bank accounts.
Original exchange filing (PDF)
More announcements from Trualt Bioenergy Ltd
- Intimation regarding receipt of allocation for Supply of Ethanol - ESY 2026-27 路 13 Nov 2026
- Earnings Call Transcript 路 29 Oct 2026
- Intimation of recording of earnings call held on 26 October 2026 路 26 Oct 2026
- Results-Financial Results for September 30,2026. 路 24 Oct 2026
- Press Release under Regulation 30 of SEBI (LODR) Regulations 2015 路 24 Oct 2026
- Investor Presentation 路 24 Oct 2026
- Outcome of Board Meeting for approval of Unaudited Financial Results(Standalone and Consolidated) along with Limited Review Report thereon, for the Quarter and Half Year ended on September 30, 2026. 路 24 Oct 2026
- TruAlt Bioenergy Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 24 Oct 2026
